KOLON Biotech is a Korean CDMO that provides continuous research and development, production, and a global network of facilities to advance pharmaceutical projects across a range of modalities. The company's chemical business consists of clinical- to commercial-scale CDMO services, including development and GMP manufacturing of (DS) APIs, intermediates, and specialty chemical materials, as well as a robust portfolio of generic APIs. Powered by the success of their chemical services, KOLON is expanding into biopharmaceutical and cell and gene therapy development and manufacturing.